TriangleNCT01026220 · OUTCOME
Event-free Survival for Rapid Early Response (RER) Positron Emission Tomography(PET)-1 Positive, RER PET-1 Negative
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- Probability of survival
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- 3 years from enrollment
What was measured
To investigate whether very early response assessment measured by Fluorodeoxyglucose-PET after 1 cycle of chemotherapy identifies a subject cohort that can be studied in future trials and that is distinguishable from currently defined RER after 2 cycles.
Analysis population: RER with positive PET-1, Event-Free Survival for RER PET-1 positive patients is compared to that of RER with negative PET-1: n=57 PET-1 positive RER patients, compared to 2 events among n=20 PET-1 negative RER patients. Two PET-1 equivocal RER patients (1 with relapse and 1 censored) are not included in this analysis.
Groups in this outcome
Group 1
All Patients
Group 4
RER PET-1 positive
Group 5
RER PET-1 negative
| Group | Source count |
|---|---|
| Group 1 | 77 |
| Group 4 | 57 |
| Group 5 | 20 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Group 1 | 0.84 | Not reported | 0.73 | 0.91 | Not reported |
| Group 4 | 0.82 | Not reported | 0.69 | 0.90 | Not reported |
| Group 5 | 0.90 | Not reported | 0.65 | 0.97 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 0.73
- upper Limit
- 0.91
- value
- 0.84
- group Id
- OG001
- lower Limit
- 0.69
- upper Limit
- 0.90
- value
- 0.82
- group Id
- OG002
- lower Limit
- 0.65
- upper Limit
- 0.97
- value
- 0.90
- denoms
- counts
- group Id
- OG000
- value
- 77
- group Id
- OG001
- value
- 57
- group Id
- OG002
- value
- 20
- units
- Participants
- description
- To investigate whether very early response assessment measured by Fluorodeoxyglucose-PET after 1 cycle of chemotherapy identifies a subject cohort that can be studied in future trials and that is distinguishable from currently defined RER after 2 cycles.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- All Patients
- id
- OG000
- title
- Group 1
- description
- RER PET-1 positive
- id
- OG001
- title
- Group 4
- description
- RER PET-1 negative
- id
- OG002
- title
- Group 5
- param Type
- NUMBER
- population Description
- RER with positive PET-1, Event-Free Survival for RER PET-1 positive patients is compared to that of RER with negative PET-1: n=57 PET-1 positive RER patients, compared to 2 events among n=20 PET-1 negative RER patients. Two PET-1 equivocal RER patients (1 with relapse and 1 censored) are not included in this analysis.
- reporting Status
- POSTED
- time Frame
- 3 years from enrollment
- title
- Event-free Survival for Rapid Early Response (RER) Positron Emission Tomography(PET)-1 Positive, RER PET-1 Negative
- type
- SECONDARY
- unit Of Measure
- Probability of survival
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice